CXCR6+ CD8+ T cells are frequently found in tumors and are associated with improved survival outcomes in cancer patients (12), as well as enhanced antitumor responses and better efficacy of checkpoint blockade therapies (14). This evidence concerns the gene CXCR6 and cancer.